Surmodics reported $18.77M in Gross Profit on Sales for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abbott ABT:US $ 5276M 780M
Align Technology ALGN:US $ 758.54M 81.44M
Anika Therapeutics ANIK:US $ 20.81M 0.16M
Baxter International BAX:US $ 1242M 77M
Bioscrip BIOS:US $ 198.97M 33.49M
Boston Scientific BSX:US $ 2120M 274M
Cryolife CRY:US $ 50.51M 2.68M
Edap Tms EDAP:US $ 4.22M 0.15M
Edwards Lifesciences EW:US $ 1041.7M 118.5M
Genmark Diagnostics GNMK:US $ 19.4M 2.86M
Haemonetics HAE:US $ 110.34M 28.36M
Heron Therapeutics HRTX:US $ 7.92M 2.89M
Johnson & Johnson JNJ:US $ 15725M 440M
Merit Medical Systems MMSI:US $ 124.14M 12.24M
Mesa Laboratories MLAB:US $ 22.21M 2.52M
Nektar Therapeutics NKTR:US $ 20.66M 2.77M
Oxford Immunotec Global OXFD:US $ 14.86M 11.19M
Providence Service PRSC:US $ 94.88M 1.6M
Stryker SYK:US $ 2712M 281M
Surmodics SRDX:US $ 18.77M 12.06M